Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review.
Journal
The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
23
11
2021
revised:
26
01
2022
accepted:
26
01
2022
pubmed:
17
4
2022
medline:
31
8
2022
entrez:
16
4
2022
Statut:
ppublish
Résumé
Understanding why some migrants in Europe are at risk of underimmunisation and show lower vaccination uptake for routine and COVID-19 vaccines is critical if we are to address vaccination inequities and meet the goals of WHO's new Immunisation Agenda 2030. We did a systematic review (PROSPERO: CRD42020219214) exploring barriers and facilitators of vaccine uptake (categorised using the 5As taxonomy: access, awareness, affordability, acceptance, activation) and sociodemographic determinants of undervaccination among migrants in the EU and European Economic Area, the UK, and Switzerland. We searched MEDLINE, CINAHL, and PsycINFO from 2000 to 2021 for primary research, with no restrictions on language. 5259 data sources were screened, with 67 studies included from 16 countries, representing 366 529 migrants. We identified multiple access barriers-including language, literacy, and communication barriers, practical and legal barriers to accessing and delivering vaccination services, and service barriers such as lack of specific guidelines and knowledge of health-care professionals-for key vaccines including measles-mumps-rubella, diphtheria-pertussis-tetanus, human papillomavirus, influenza, polio, and COVID-19 vaccines. Acceptance barriers were mostly reported in eastern European and Muslim migrants for human papillomavirus, measles, and influenza vaccines. We identified 23 significant determinants of undervaccination in migrants (p<0·05), including African origin, recent migration, and being a refugee or asylum seeker. We did not identify a strong overall association with gender or age. Tailored vaccination messaging, community outreach, and behavioural nudges facilitated uptake. Migrants' barriers to accessing health care are already well documented, and this Review confirms their role in limiting vaccine uptake. These findings hold immediate relevance to strengthening vaccination programmes in high-income countries, including for COVID-19, and suggest that tailored, culturally sensitive, and evidence-informed strategies, unambiguous public health messaging, and health system strengthening are needed to address access and acceptance barriers to vaccination in migrants and create opportunities and pathways for offering catch-up vaccinations to migrants.
Identifiants
pubmed: 35429463
pii: S1473-3099(22)00066-4
doi: 10.1016/S1473-3099(22)00066-4
pmc: PMC9007555
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Review
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e254-e266Subventions
Organisme : Medical Research Council
ID : MRC/N013638/1
Pays : United Kingdom
Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests HB is a member of the National Institute for Health and Care Excellence committee developing guidance on vaccine uptake in the general population. SH is a freelance senior editor for The Lancet Infectious Diseases and other Lancet journals. FW is a member of the Vulnerable Migrants Wellbeing Project Advisory Board, led by the University of Birmingham and Doctors of the World and funded by the Nuffield Foundation. All other authors declare no competing interests.
Références
Vaccine. 2015 Apr 27;33(18):2125-31
pubmed: 25796339
Aten Primaria. 2005 Feb 28;35(3):164
pubmed: 15737275
Z Gastroenterol. 2010 Sep;48(9):1126-32
pubmed: 20839162
Public Health. 2021 Jul;196:138-145
pubmed: 34214751
Vaccine. 2019 May 6;37(20):2661-2669
pubmed: 30967311
Vaccine. 2008 Aug 5;26(33):4218-23
pubmed: 18579263
Br J Gen Pract. 2021 Jul 29;71(709):e583-e595
pubmed: 33875420
Eur J Public Health. 2014 Apr;24(2):304-9
pubmed: 23531526
Public Health. 2011 Aug;125(8):505-11
pubmed: 21802701
Papillomavirus Res. 2016 Dec;2:78-84
pubmed: 29074189
Vaccine. 2009 Apr 28;27(19):2563-9
pubmed: 19428862
Vaccine. 2020 Jan 22;38(4):709-711
pubmed: 31836257
Prev Med Rep. 2018 Feb 23;10:93-99
pubmed: 29868358
Health Promot Int. 2019 Oct 1;34(5):e36-e46
pubmed: 30189003
Vaccine. 2007 Apr 20;25(16):3240-3
pubmed: 17320249
J Migr Health. 2021;3:100041
pubmed: 33903857
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Arch Dis Child. 2005 Jan;90(1):36-40
pubmed: 15613508
Int J Environ Res Public Health. 2019 May 09;16(9):
pubmed: 31075829
Euro Surveill. 2019 Jul;24(27):
pubmed: 31290391
Vaccine. 2010 Feb 25;28(9):2070-5
pubmed: 20045095
Vaccine. 2018 Sep 11;36(38):5747-5753
pubmed: 30111513
BMC Public Health. 2015 Dec 10;15:1229
pubmed: 26654538
Prev Med. 2015 Aug;77:4-10
pubmed: 25944266
Eur J Pediatr. 2018 Jul;177(7):1057-1062
pubmed: 29713812
Ind Health. 2016 Dec 7;54(6):554-563
pubmed: 27251030
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Eur J Cancer Prev. 2018 Jan;27(1):42-45
pubmed: 27307374
BMC Public Health. 2020 Sep 10;20(1):1381
pubmed: 32912161
Eur J Public Health. 2013 Apr;23(2):265-9
pubmed: 22683768
Health Expect. 2015 Jun;18(3):344-54
pubmed: 23252449
J Health Psychol. 2012 Apr;17(3):443-52
pubmed: 21900335
Lancet. 2021 Jan 2;397(10268):8-10
pubmed: 33308484
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 May;59(5):584-91
pubmed: 27090248
Lancet. 2021 Jul 17;398(10296):211-212
pubmed: 34274061
J Adolesc Health. 2015 Apr;56(4):402-7
pubmed: 25659994
Aten Primaria. 2010 May;42(5):266-72
pubmed: 20129705
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 May;59(5):592-8
pubmed: 27072499
Vaccines (Basel). 2021 Jun 21;9(6):
pubmed: 34205585
Vaccine. 2011 Jun 10;29(26):4405-8
pubmed: 21501645
BMC Public Health. 2020 Mar 23;20(1):381
pubmed: 32293379
Lancet Infect Dis. 2021 Dec;21(12):e387-e398
pubmed: 34626552
BMJ. 2019 Sep 16;366:l4160
pubmed: 31527060
Euro Surveill. 2018 Oct;23(41):
pubmed: 30326996
J Migr Health. 2021;4:100050
pubmed: 34075367
Eur J Pediatr. 2020 Jan;179(1):171-175
pubmed: 31701239
Vaccine. 2019 May 6;37(20):2741-2747
pubmed: 30979570
J Glob Health. 2019 Jun;9(1):010432
pubmed: 31217960
BMC Health Serv Res. 2018 Nov 14;18(1):859
pubmed: 30428869
Vaccine. 2015 Sep 11;33(38):4994-9
pubmed: 26151543
J Travel Med. 2021 Jun 1;28(4):
pubmed: 33611577
PLoS One. 2019 Dec 26;14(12):e0226948
pubmed: 31877563
BMC Public Health. 2021 Jan 7;21(1):93
pubmed: 33413287
PLoS One. 2011;6(6):e20900
pubmed: 21695074
Arch Pediatr. 2012 Mar;19(3):242-7
pubmed: 22226013
Eur J Public Health. 2020 Aug 1;30(4):697-702
pubmed: 32361768
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
Int J Environ Res Public Health. 2020 Apr 21;17(8):
pubmed: 32326203
J Health Soc Behav. 2014 Sep;55(3):342-59
pubmed: 25138201
Vaccine. 2020 Mar 17;38(13):2795-2799
pubmed: 32089460
Vaccine. 2019 Aug 23;37(36):5439-5451
pubmed: 31296374
Vaccine. 2018 Feb 14;36(8):1055-1062
pubmed: 29395515
J Travel Med. 2021 Jun 1;28(4):
pubmed: 33772312
Infection. 2006 Jun;34(3):135-41
pubmed: 16804656
Eur J Pediatr. 2008 Oct;167(10):1161-8
pubmed: 18204860
Public Health. 2018 May;158:110-116
pubmed: 29653865
Vaccine. 2015 Apr 8;33(15):1767-72
pubmed: 25731790
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
BMC Public Health. 2021 Apr 7;21(1):668
pubmed: 33827509
BMC Health Serv Res. 2019 Jun 27;19(1):429
pubmed: 31248420
Curr Opin Immunol. 2021 Aug;71:62-68
pubmed: 34118728
Vaccine. 2018 Nov 26;36(49):7536-7541
pubmed: 30420043
J Infect Public Health. 2013 Feb;6(1):1-9
pubmed: 23290087
BMJ. 2021 Feb 26;372:n513
pubmed: 33637577
Br J Gen Pract. 2019 Aug;69(685):e537-e545
pubmed: 30745354
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34292869
Int J Equity Health. 2015 Aug 21;14:68
pubmed: 26293806
J Infect. 2008 Dec;57(6):472-80
pubmed: 19010553
Vaccine. 2020 Jul 22;38(34):5516-5524
pubmed: 32593605
J Migr Health. 2021;4:100051
pubmed: 34184000
PLoS One. 2017 Oct 2;12(10):e0178122
pubmed: 28968403
BMC Public Health. 2017 Mar 14;17(1):254
pubmed: 28288596
J Infect Dev Ctries. 2019 Dec 31;13(12):1159-1164
pubmed: 32088704
Travel Med Infect Dis. 2021 Jan-Feb;39:101715
pubmed: 32389827
Eur J Cancer Prev. 2020 Mar;29(2):149-156
pubmed: 31425314
Health Policy. 2012 Apr;105(1):17-24
pubmed: 22385905
Infection. 2016 Dec;44(6):781-787
pubmed: 27449329
Public Health. 2019 Jun;171:97-105
pubmed: 31121558
Pathog Glob Health. 2017 Mar;111(2):59-68
pubmed: 28165878
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Oct;56(10):1368-75
pubmed: 23978983
Eur J Obstet Gynecol Reprod Biol. 2014 Jul;178:163-8
pubmed: 24793932
Cent Eur J Public Health. 2018 Jun;26(2):132-136
pubmed: 30102502
Int J Public Health. 2008;53(4):180-7
pubmed: 18716721
J R Soc Med. 2021 May;114(5):240-243
pubmed: 33689530
Vaccine. 2018 Oct 22;36(44):6556-6558
pubmed: 28830694
BMC Public Health. 2020 Jun 30;20(1):1039
pubmed: 32605605
J Immigr Minor Health. 2016 Apr;18(2):353-9
pubmed: 25774037
BMC Public Health. 2021 May 3;21(1):854
pubmed: 33941126
Lancet. 2018 May 5;391(10132):1752-1754
pubmed: 29739550
Vaccine. 2016 Feb 17;34(8):1018-24
pubmed: 26672676